The study analyzed that the candidiasis therapeutics pipeline comprises approximately 22 drug candidates in different stages of development. Matinas Biopharma Holdings, Inc. is using Cochleate technology platform for the development of the…
Quote saved.
Login to quote this blog
Failed to save quote. Please try again later.
You cannot quote because this article is private.